BMY logo

BMY
Bristol-Myers Squibb Co.

20,682
Mkt Cap
$118.58B
Volume
8.18M
52W High
$62.89
52W Low
$42.52
PE Ratio
16.79
BMY Fundamentals
Price
$57.89
Prev Close
$58.08
Open
$58.00
50D MA
$59.71
Beta
0.32
Avg. Volume
13.99M
EPS (Annual)
$3.46
P/B
6.40
Rev/Employee
$1.48M
$146,482.66
Loading...
Loading...
News
all
press releases
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
BMY's Breyanzi tops $1B run rate in 2025, expanding across five cancers with new FDA nod, strengthening its CAR T leadership despite rising competition.
Zacks·2h ago
News Placeholder
More News
News Placeholder
Pfizer's Non-Oncology Portfolio in Focus Ahead of Q1 Earnings
PFE's non-oncology portfolio is in focus ahead of Q1, with Eliquis and Prevnar gains expected to be offset by declines in Comirnaty, Paxlovid and some specialty drugs
Zacks·7h ago
News Placeholder
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks·8h ago
News Placeholder
Will Keytruda Continue to Aid Merck's Top Line in Q1 Earnings?
MRK's Keytruda, driving over half of its pharma sales, remains in focus as Q1 nears, with growth expected from new indications and strong uptake.
Zacks·8h ago
News Placeholder
Patten Group Inc. Invests $1.04 Million in Bristol Myers Squibb Company $BMY
Patten Group Inc. purchased a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·10h ago
News Placeholder
Massachusetts Financial Services Co. MA Increases Stock Position in Bristol Myers Squibb Company $BMY
Massachusetts Financial Services Co. MA boosted its holdings in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 835.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 768,040 shares...
MarketBeat·11h ago
News Placeholder
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
REPL stock plunges after a second FDA CRL delays RP1 melanoma approval, casting doubt on its regulatory path and near-term growth plans.
Zacks·2d ago
News Placeholder
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Zacks·2d ago
News Placeholder
State of Alaska Department of Revenue Sells 59,405 Shares of Bristol Myers Squibb Company $BMY
State of Alaska Department of Revenue decreased its holdings in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 18.7% during the 4th quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Bristol Myers Squibb Company $BMY Stock Position Lifted by Burney Co.
Burney Co. grew its position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 507.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·3d ago
<
1
2
...
>

Latest BMY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.